Page last updated: 2024-09-02

kahweol and ER-Negative PR-Negative HER2-Negative Breast Cancer

kahweol has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Kang, YJ; Kim, HS; Kim, J; Lee, JH	1

Other Studies

1 other study(ies) available for kahweol and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Unraveling Connective Tissue Growth Factor as a Therapeutic Target and Assessing Kahweol as a Potential Drug Candidate in Triple-Negative Breast Cancer Treatment. International journal of molecular sciences, 2023, Nov-14, Volume: 24, Issue:22 Topics: Cell Line, Tumor; Cell Proliferation; Connective Tissue Growth Factor; Diterpenes; Humans; Pharmaceutical Preparations; Phosphatidylinositol 3-Kinases; Triple Negative Breast Neoplasms	2023

Article

Year

Unraveling Connective Tissue Growth Factor as a Therapeutic Target and Assessing Kahweol as a Potential Drug Candidate in Triple-Negative Breast Cancer Treatment.

International journal of molecular sciences, 2023, Nov-14, Volume: 24, Issue:22

Topics: Cell Line, Tumor; Cell Proliferation; Connective Tissue Growth Factor; Diterpenes; Humans; Pharmaceutical Preparations; Phosphatidylinositol 3-Kinases; Triple Negative Breast Neoplasms

2023